Disease Overview：Adenomyosis（AD）
Adenomyosis is a benign gynecological condition characterized by the ectopic implantation of endometrial glandular and stromal tissue into the myometrium, resulting in uterine enlargement, chronic pelvic pain, menorrhagia, dysmenorrhea, and, in some cases, infertility or recurrent pregnancy loss. Diagnosis typically relies on transvaginal ultrasound with expert morphological assessment—particularly using the “junctional zone” evaluation—or MRI for atypical presentations. While medical management (e.g., GnRH agonists, progestin-releasing intrauterine systems) may alleviate symptoms, definitive treatment often requires surgical intervention such as laparoscopic or robotic-assisted adenomyomectomy, especially for patients desiring fertility preservation. In severe or diffuse cases, hysterectomy remains an option—but increasingly, minimally invasive, uterus-sparing approaches are prioritized.
China offers distinct advantages for adenomyosis care: leading reproductive medicine centers—many affiliated with top-tier universities—employ internationally trained specialists skilled in complex myometrial resection and fertility-sparing techniques. Advanced imaging modalities (3T MRI, 3D-ultrasound elastography), high-precision robotic platforms (da Vinci Xi), and integrated IVF-embryo transfer protocols enhance both diagnostic accuracy and functional outcomes. Clinical data from institutions like Peking University Third Hospital and Shanghai Jiao Tong University Affiliated International Peace Maternity and Child Health Hospital demonstrate cumulative live birth rates exceeding 50% post-adenomyomectomy in carefully selected infertile patients. Treatment costs in China average 40–60% lower than in the US or Western Europe, without compromising evidence-based standards or regulatory oversight.
As a dedicated medical tourism agency, we facilitate seamless access to these resources for international patients—handling hospital referrals, coordinating pre-arrival diagnostics, ensuring transparent all-inclusive pricing, and providing multilingual clinical support, accommodation logistics, and post-treatment follow-up coordination.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Adenomyosis (Reproductive Medicine Department)
Non-Surgical / Conservative Medical Management
*Target criteria:* Symptomatic patients with mild–moderate dysmenorrhea, menorrhagia, or infertility; desire fertility preservation; contraindications to surgery.
- •Hormonal Therapy (Tier 1 – First-line)
- Progestin-only pills (e.g., dienogest): ¥280–¥560/month ($40–$80) - GnRH agonist (leuprolide depot, 3.75 mg): ¥1,800–¥2,400/dose ($257–$343) × 3–6 months
- •Adjunctive Examinations & Monitoring
- Serum CA-125: ¥85 ($12) - Hemoglobin + ferritin (anemia workup): ¥190 ($27) - Endometrial biopsy (if abnormal bleeding): ¥320 ($46)
Surgical / Interventional Procedures
*Eligibility criteria:* Severe symptoms refractory to ≥6 months medical therapy; large adenomyotic nodules (>4 cm); coexisting fibroids or endometriosis; no immediate fertility plans.
- •Uterine Artery Embolization (UAE)
- Procedure (bilateral UAE + angiography): ¥18,000–¥25,000 ($2,570–$3,570)
- •Laparoscopic Focal Adenomyomectomy
- Surgery (including intraoperative ultrasound, suture materials): ¥28,000–¥42,000 ($4,000–$6,000)
- •Total Laparoscopic Hysterectomy
- Surgery (including robotic-assisted option in select centers): ¥35,000–¥58,000 ($5,000–$8,290)
Special / Complex Condition Management
- •Adenomyosis with Infertility & IVF Failure
- High-resolution 3D pelvic MRI + diffusion-weighted imaging: ¥1,350 ($193)
- •Diffuse Adenomyosis + Severe Anemia (Hb <8 g/dL)
- Intrauterine balloon tamponade + tranexamic acid infusion: ¥2,100 ($300)
Quick Selection Guide
- •<35 years, fertility-seeking, moderate symptoms: Start with dienogest + transvaginal US monitoring ($40–$37/month). Add GnRH agonist pre-IVF if recurrent implantation failure.
- •35–45 years, severe pain/anemia, no fertility plans: UAE offers symptom relief with uterine preservation ($2,570–$3,570); avoid if future pregnancy desired.
- •>45 years, refractory menorrhagia + anemia: Laparoscopic hysterectomy provides definitive cure ($5,000–$8,290) and eliminates recurrence risk.
- •Budget-constrained (<$500 total): Combined oral contraceptives + NSAIDs + iron supplementation ($17–$43/month, cumulative $200–$500/year).
- •Comorbid endometriosis or deep infiltrating disease: Requires integrated laparoscopic excision + adenomyomectomy ($4,000–$6,000) — not amenable to UAE alone.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Adenomyosis Medical Vacation Packages
Curated transparent all-inclusive packages combining Adenomyosis treatment with China top medical destinations:
